Home
›
Aspire Biopharma Holdings, Inc.
› SCHEDULE 13G/A May 7, 2025
Aspire Biopharma Holdings, Inc. (ASBP): SCHEDULE 13G/A filed May 7, 2025
Form type
SCHEDULE 13G/A
Filing date
May 7, 2025
Accession number
0001641172-25-009072
Filer
Aspire Biopharma Holdings, Inc.
(CIK 1847345)